The Supreme People’s Court has identified certain relevant factors when assessing such agreements from an antitrust perspective. The Chinese entity of a multinational medical device manufacturer was fined RMB 9.12 million for RPM, representing 3% of its 2020 total China-wide revenue. The antitrust authority will be stepping up oversight over the platform economy, technology development, data security and livelihood sectors such as utilities, healthcare and medicine.
The first draft, released on 2 March 2022, is the authority’s first comprehensive overview of competition issues specific to the digital economy and its enforcement position and policy direction. This update was published as part of our quarterly newsletter, Asia Pacific Competition Highlights.
As 2021 came to a close, we invited C-Suite leaders from across Asia Pacific to share their insights and concerns about engaging with long-term ESG targets. The key themes presented here are gathered from our closed-door roundtable, which was conducted in accordance with Chatham House rules. Participants identified five key facets of the challenges, opportunities and outlook facing C-suite leaders in the region as they strive to advance ESG strategy and drive meaningful action.
As part of our continued efforts to guide clients through these challenging times, the Asia Pacific Employment & Compensation Group brings you these recorded webinars which provide key and practical insights on employment and compensation trends and major challenges being faced by businesses across the region.